Literature DB >> 30444942

Harnessing stem cells and biomaterials to promote neural repair.

K F Bruggeman1, N Moriarty2, E Dowd2, D R Nisbet1, C L Parish3.   

Abstract

With the limited capacity for self-repair in the adult CNS, efforts to stimulate quiescent stem cell populations within discrete brain regions, as well as harness the potential of stem cell transplants, offer significant hope for neural repair. These new cells are capable of providing trophic cues to support residual host populations and/or replace those cells lost to the primary insult. However, issues with low-level adult neurogenesis, cell survival, directed differentiation and inadequate reinnervation of host tissue have impeded the full potential of these therapeutic approaches and their clinical advancement. Biomaterials offer novel approaches to stimulate endogenous neurogenesis, as well as for the delivery and support of neural progenitor transplants, providing a tissue-appropriate physical and trophic milieu for the newly integrating cells. In this review, we will discuss the various approaches by which bioengineered scaffolds may improve stem cell-based therapies for repair of the CNS.
© 2018 The British Pharmacological Society.

Mesh:

Substances:

Year:  2018        PMID: 30444942      PMCID: PMC6329623          DOI: 10.1111/bph.14545

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  106 in total

1.  Controlled growth factor delivery for tissue engineering.

Authors:  Prakriti Tayalia; David J Mooney
Journal:  Adv Mater       Date:  2009-09-04       Impact factor: 30.849

2.  Interaction of embryonic cortical neurons on nanofibrous scaffolds for neural tissue engineering.

Authors:  D R Nisbet; S Pattanawong; N E Ritchie; W Shen; D I Finkelstein; M K Horne; J S Forsythe
Journal:  J Neural Eng       Date:  2007-01-31       Impact factor: 5.379

Review 3.  Molecular mechanisms of axon guidance.

Authors:  John K Chilton
Journal:  Dev Biol       Date:  2006-02-14       Impact factor: 3.582

4.  Encapsulation of proteins in poly(L-lactide-co-caprolactone) fibers by emulsion electrospinning.

Authors:  Xiaoqiang Li; Yan Su; Shuiping Liu; Lianjiang Tan; Xiumei Mo; Seeram Ramakrishna
Journal:  Colloids Surf B Biointerfaces       Date:  2009-09-22       Impact factor: 5.268

5.  Incorporation and release of dual growth factors for nerve tissue engineering using nanofibrous bicomponent scaffolds.

Authors:  Chaoyu Liu; Chong Wang; Qilong Zhao; Xiaohua Li; Feiyue Xu; Xumei Yao; Min Wang
Journal:  Biomed Mater       Date:  2018-05-04       Impact factor: 3.715

6.  Combinated transplantation of neural stem cells and collagen type I promote functional recovery after cerebral ischemia in rats.

Authors:  Hongwei Yu; Bo Cao; Meiyan Feng; Qiang Zhou; Xiaodong Sun; Shuliang Wu; Shizhu Jin; Huiwen Liu; Jin Lianhong
Journal:  Anat Rec (Hoboken)       Date:  2010-05       Impact factor: 2.064

7.  Functional recovery of the murine brain ischemia model using human induced pluripotent stem cell-derived telencephalic progenitors.

Authors:  Masanori Gomi; Yasushi Takagi; Asuka Morizane; Daisuke Doi; Masaki Nishimura; Susumu Miyamoto; Jun Takahashi
Journal:  Brain Res       Date:  2012-03-28       Impact factor: 3.252

8.  Self-healing polysaccharide-based hydrogels as injectable carriers for neural stem cells.

Authors:  Zhao Wei; Jingyi Zhao; Yong Mei Chen; Pengbo Zhang; Qiqing Zhang
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

9.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

10.  A PITX3-EGFP Reporter Line Reveals Connectivity of Dopamine and Non-dopamine Neuronal Subtypes in Grafts Generated from Human Embryonic Stem Cells.

Authors:  Jonathan C Niclis; Carlos W Gantner; Cameron P J Hunt; Jessica A Kauhausen; Jennifer C Durnall; John M Haynes; Colin W Pouton; Clare L Parish; Lachlan H Thompson
Journal:  Stem Cell Reports       Date:  2017-08-31       Impact factor: 7.765

View more
  7 in total

1.  Extracellular Matrix Biomimetic Hydrogels, Encapsulated with Stromal Cell-Derived Factor 1, Improve the Composition of Foetal Tissue Grafts in a Rodent Model of Parkinson's Disease.

Authors:  Vanessa Penna; Niamh Moriarty; Yi Wang; Kevin C L Law; Carlos W Gantner; Richard J Williams; David R Nisbet; Clare L Parish
Journal:  Int J Mol Sci       Date:  2022-04-22       Impact factor: 6.208

Review 2.  Evolving principles underlying neural lineage conversion and their relevance for biomedical translation.

Authors:  Lea Jessica Flitsch; Oliver Brüstle
Journal:  F1000Res       Date:  2019-08-30

Review 3.  Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer's Disease.

Authors:  Qingqing Yin; Xiaojuan Ji; Renjun Lv; Jin-Jing Pei; Yifeng Du; Chao Shen; Xunyao Hou
Journal:  Clin Interv Aging       Date:  2020-02-13       Impact factor: 4.458

4.  Human Growth Factor/Immunoglobulin Complexes for Treatment of Myocardial Ischemia-Reperfusion Injury.

Authors:  Benjamin Liebman; Claire Schwaegler; Andrea T Foote; Krithika S Rao; Taylor Marquis; Alexander Aronshtam; Stephen P Bell; Prospero Gogo; Richard R LaChapelle; Jeffrey L Spees
Journal:  Front Bioeng Biotechnol       Date:  2022-02-28

5.  A Hydrogel as a Bespoke Delivery Platform for Stromal Cell-Derived Factor-1.

Authors:  Yi Wang; Vanessa Penna; Richard J Williams; Clare L Parish; David R Nisbet
Journal:  Gels       Date:  2022-04-06

Review 6.  Neuronal Replacement as a Tool for Basal Ganglia Circuitry Repair: 40 Years in Perspective.

Authors:  Anders Björklund; Malin Parmar
Journal:  Front Cell Neurosci       Date:  2020-05-29       Impact factor: 5.505

Review 7.  Progress in the Development of Graphene-Based Biomaterials for Tissue Engineering and Regeneration.

Authors:  Chao Chen; Yuewei Xi; Yunxuan Weng
Journal:  Materials (Basel)       Date:  2022-03-15       Impact factor: 3.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.